98 KB25 KB192920262004Baraga-Žiberna, LudvikaKavaš, ErikaLokar, LidijaMaček, MarjetaMaver, SlavicaPajk, JanjaPotočnik, MarjetaStrmčnik, LidijaŠeruga-Doliška, MarijaUrbajs, MatjažZalokar, ZojaZavadlav, Jankastr. I-97 - I-100ISSN:1318-0347COBISSID_HOST:1507135URN:URN:NBN:SI:doc-C7228P3WslSlovensko zdravniško društvoZdravniški vestnikBlood transfusionKakovostQualitySafetyTransfuzija krviVarnostPrijave neželenih škodljivih učinkov transfuzije krvi v Sloveniji v letu 2002| Reports of adverse events to blood transfusion in Slovenia in 2002|Background. The risk of severe adverse events to blood transfusion is very low. More frequent are adverse events to transfusion, which are not severe, but must also be treated. Introduction of the haemovigilance system is a way of detecting and analysing them in order to correct their cause and to prevent their recurrence. Methods. In 2002 we collected data on transfusion adverse events registered by the Blood Transfusion Centre of Slovenia and blood transfusion departments in Slovene general hospitals. Results. 86 adverse events to transfusion were reported in 2002. The most frequent were non-haemolytic fever (42 cases) and allergic reactions (27 cases). 5 cases of haemolysis and 1 of pulmonary oedema were also reported. 11 cases were not categorised. Conclusions. We suppose that the collected data is not complete. However, it does give us insight into the clinical part of the transfusion chain. The most frequently registered adverse events in Slovenia are the same as in other countries. The presented data is the beginning of a systematic registration, using standard forms and reporting. Analysis and a follow-up activities are the basis for improvement of the blood transfusion safety and quality of treatmentIzhodišča. Resni, življenje ogrožujoči zapleti ob transfuziji redko nastopijo, pogosteje pa se pojavljajo zapleti, ki življenja sicer ne ogrožajo, vendar prav tako zahtevajo zdravniško obravnavo. V okviru sistema hemovigilance spremljamo zaplete zaradi transfuzije zato, da bi jih v prihodnosti z ustreznimi ukrepi preprečili. Metode. Zbrali smo podatke o neželenih škodljivih učinkih transfuzije, ki so jih zdravniki v letu 2002 prijavili Zavodu RS za transfuzijsko medicino in transfuzijskim oddelkom slovenskih splošnih bolnišnic. Rezultati. V leti 2002 so v Sloveniji prijavili 86 primerov neželenih škodljivih učinkov transfuzije. Največ je bilo febrilnih nehemolitičnih (42) in alergičnih (27) transfuzijskih reakcij. Hemolitična reakcija je nastopila v 5 primerih, pljučni edem pa v 1 primeru. V 11 primerih zaplet ni bil opredeljen. Zaključki. Sklepamo, da so podatki nepopolni, kljub temu pa nam dajejo vpogled v dogajanje pri bolnikih po transfuziji krvi. Najpogosteje zabeleženi neželeni škodljivi učinki transfuzije v Sloveniji so enaki kot v drugih državah. Zbrani podatki so začetek sistematičnega zbiranja podatkov v okviru sistema hemovigilance, z enotnimi obrazci in potmi sporočanja. Analiza in ustrezni ukrepi so osnova za večjo varnost transfuzije krvi in s tem bolj kakovostno zdravstveno storitevTEXTznanstveno časopisjejournalsSlovenian National E-content AggregatorNational and University Library of SloveniaSlovensko zdravniško društvo